Opening words - Barbara Ralston, Stanford Hospital and Clinics
Genomics, Pharmacogenomics and Personalized Medicine - Professor Michael Goldman, San Francisco State University
What do Physicians want from Genomics? - Robert Nussbaum, MD UCSF
Building a Value Proposition for Personalized Medicine: The Good, the Bad, and the Ugly - Kathryn Phillips, Ph.D. UCSF
Development and Commercialization of New Therapeutics and Companion Diagnostics - Mary Haak-Frendscho, Ph.D. (Takeda Pharmaceuticals San Francisco), Gregory Heath, Ph.D. (Illumina), Rick Hockett, MD (AFFYMETRIX, INC.), Hakan Sakul, Ph.D (Pfizer), Cecilia Schott, PharmD., MBA (AstraZeneca), Yael Weiss, MD, Ph.D (Merck), and Moderator: John Steuart (Claremont Creek Ventures)
11:20am PharmGKB: Curating and Storing the World's Pharmacogenomic Knowledge - Professor Russ Altman, Stanford University
Integrating Genomic Medicine into Patient Care - Trisha Brown, DNA Direct
A Personal Genome - Professor Stephen Quake, Stanford University
Value-based Pricing and Sustainable Growth for Personalized Medicine - Patrick Terry, Technic Solutions LLC
Implementing Pharmacogenomics into Clinical Practice - Professor Alan Wu, UCSF Pathology & Laboratory Medicine
FDA Regulation: Challenges and Solutions - Elizabeth Mansfield, Ph.D., FDA
Bringing Preventive Genomic into Clinical Practice - Vance Vanier, M.D., Navigenics
Patients Like Me: Role of multimodal mining in personalized medicine - Tanveer Syeda-Mahmood Ph.D., IBM
Fit for the BeneFit: Translation towards Personalized Medicine - Multiple Sclerosis as a model - Professor Ariel Miller, M.D., Ph.D., Technion, Israel
Trend in Personalized Medicine - Scott Jenkins, Ph.D., Dell
Systems Medicine, Transformational Technologies and the Emergence of Proactive P4 Medicine - Leroy Hood M.D Ph.D., Institute for Systems Biology
Bridging the Gap Between Needed Technical Standards and the Rapid Innovation - Michael.D. Amos, Ph.D. NIST, US Government
Enabling Personalized Medicine with Healthcare IT - Michael Cantor, M.D., Pfizer
The Revolution in Genomics and Emergence of PM - Clifford Reid, Ph.D., Complete Genomics
Personalized Medicine for Diseases of the Immune System - Paul J. Utz, M.D., Stanford University
Investing in Personalized Medicine: Are we there yet? The Promise, the Challenges and the Rewards - Brook Byers (Kleiner Perkins Caufield & Byers), Sue Siegel (MDV), Mickey Urdea Ph.D. (Tethys Bioscience, Inc.), Vijay Lathi (New Leaf Venture Partners) and Moderator: Stephen Thau (Morrison Forester)
Consumer Web Tools for Personalized Health Maintenance/ Prevention/ Monitoring - Esther Dyson
Personalized Medicine: Some Real World Legal & Ethical Issues - Hank Greely, Ph.D., Stanford University
The (Giant) Missing Link: Payors Present Hurdles and Opportunities for Personalized Medicine - Bruce Quinn Ph.D., Foley Hoag
From Benchtop to Bedside: Speeding Personalized Medicine’s Translation - Paul Billings MD, PhD, Genomic Medicine Institute, El Camino Hospital
TOP 5 Company Presentations and a VC panel - Jennifer Fonstad (Draper Fisher Jurvetson), Deval A. Lashkari (Telegraph Hill Partners), Rowan Chapman Ph.D. (MDV), and Moderator - Amos Barzilay, Ph.D. (Walden International)
Overcoming the Economic Challenges of Personalized Medicine - Matthew Hudes, Deloitte Consulting LLP
PMWC 2010 "Most Promising Company" Winner Announced